AVAYL
Experience the future of medical information with AI.
AVAYL streamlines medical inquiry management for pharmaceutical companies by automating responses, reducing costs, and ensuring regulatory compliance, delivering a faster and more efficient solution for top life science companies.
Medical Information teams in pharmaceutical companies handle daily inquiries from doctors and patients, ensuring timely, evidence-based responses that comply with regulatory requirements. However, current processes are highly manual, time-consuming, and fragmented, leading to inefficiencies and significant operational costs.
AVAYL’s AI-powered SaaS transforms medical inquiry management by automating repetitive responses while ensuring scientific rigor and regulatory compliance. By integrating AI-driven workflows with regulatory-aligned content generation, the platform significantly reduces response times, optimizes resource allocation, and enhances the quality of medical information services.
AVAYL developed its solution in collaboration with leading pharmaceutical companies and industry experts. The company has successfully implemented AI-driven workflows that streamline medical inquiry management, reducing costs while improving accuracy and compliance. AVAYL serves top life science companies, delivering the industry’s leading solution in handling escalated medical inquiries.
Based in Berlin, AVAYL is led by a team of life science professionals and AI specialists, backed by high-profile investors.